Cancer

Trastuzumab Biosimilar Receives CHMP Recommendation for HER2+ Breast and Gastric Cancer

Posted on by majac

“Biosimilars have enormous potential to improve cancer care by substantially increasing access to these critical medicines.” The phase 3, …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave